XML 45 R34.htm IDEA: XBRL DOCUMENT v3.7.0.1
RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMNTS (Tables)
3 Months Ended
Mar. 31, 2017
Restatement Of Previously Issued Financial Statemnts Tables  
Schedule of restatement of previously issued financial statements

The Company has restated its previously issued financial statements as of and for the three months ended March 31, 2017, to correct the non-cash error related to its stock-based compensation.

 

The impact of the restatements is reflected below for the periods indicated:

 

CONSOLIDATED BALANCE SHEET
                   
    As of March 31, 2017  
                   
    As Previously              
    Reported     Adjustment     Restated  
                   
ASSETS      
Total assets   $ 17,388,723     $     $ 17,388,723  
                         
LIABILITIES AND STOCKHOLDERS’ DEFICIT                        
Total current liabilities     2,415,394             2,415,394  
                         
Total long-term liabilities     2,079,905             2,079,905  
        Total liabilities     4,495,299             4,495,299  
                         
Commitments and Contingencies (Note 14)                        
                         
Stockholders’ Deficit:                        
Common stock, $0.0001 par value, 500,000,000 shares                        
authorized; 344,093,411 and 234,704,655 shares issued                        
and outstanding as of March 31, 2017 and December 31, 2016, respectively     34,409             34,409  
Additional paid in capital     70,952,037       1,000,000       71,952,037  
Stock subscription receivable     (830,000 )           (830,000 )
Accumulated deficit     (57,595,085 )     (1,000,000 )     (58,595,085 )
Accumulated comprehensive income     332,063             332,063  
Total stockholders’ deficit     12,893,424             12,893,424  
Total liabilities and stockholders’ deficit   $ 17,388,723     $     $ 17,388,723  

 

CONSOLIDATED STATEMENTS OF OPERATIONS      
       
    Three months ended March 31, 2017  
             
    As Previously          
    Reported     Adjustment     Restated  
                   
Total revenues, net   $ 584,689     $     $ 584,689  
                         
Operating Expenses:                        
Cost of Sales     149,129               149,129  
General and administrative     4,255,382       1,000,000       5,255,382  
Research and development     29,070             29,070  
Depreciation and amortization     109,534             109,534  
Total operating expenses     4,543,115       1,000,000       5,543,115  
                         
Loss from operations     (3,958,426 )     (1,000,000 )     (4,958,426 )
                         
Other income (expense), net     (4,710,666 )           (4,710,666 )
                         
Income loss before income taxes     (8,669,092 )     (1,000,000 )     (9,669,092 )
                         
Income Taxes                  
                         
Net (loss)   $ (8,669,092 )   $ (1,000,000 )   $ (9,669,092 )
                         
Net (loss) per share - Basic and diluted   $ (0.03 )   $     $ (0.03 )
                         
Weighted Average Shares Outstanding - Basic and diluted     295,596,151             295,596,151  

 

STATEMENT OF COMPREHENSIVE INCOME (LOSS)
                   
    Three months ended  
                   
    As Previously              
    Reported     Adjustment     Restated  
                   
Net loss   $ (8,669,092 )   $ (1,000,000 )   $ (9,669,092 )
                         
Add:                        
                         
Foreign currency translation gain     23,452             23,452  
                         
Comprehensive loss   $ (8,645,640 )   $ (1,000,000 )   $ (9,645,640 )